About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Urotensin II in Chronic Kidney Diseases and Kidney Transplants

NCT01098799·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Vakif Gureba Training and Research Hospital

The investigators will determine the urotensin II levels in Chronic kidney disease patients, kidney transplants, and healthy controls.

Age

18–90

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Age more than 18

You may not be if

Inability to give a written consent

The record

StatusCompleted

PhaseNo phase

Taking part110

StartedApr 2010

UpdatedJun 13, 2013

Conditions

Chronic Renal Disease

Where1

Vakif Gureba Training & Research Hospital
Istanbul, Turkey (Türkiye)

Clareo Health | Urotensin II in Chronic Kidney Diseases and Kidney Transplants